Online
|
|
bonus
Posted by :
naugtyboy
i doubt-u have any idea on cash reserves or any other basis? the earlier announcements were as under
Bonus History
Announcement Date Bonus Ratio Record Date Ex-Bonus Date
11-02-2006 3:2 25-04-2006 24-04-2006
07-10-1999 2:1 05-11-1999 18-10-1999
24-03-1994 5:1 26-04-1994 04-04-1994
30-09-1992 1:1 06-11-1992 06-10-1992
11-10-1988 1:1 01-12-1988 -
23-08-1986 1:1 - -
23-08-1980 1:1 - -
...
liberal bonus
Posted by : basit222I expect CIPLA to announce liberal bonus during current FY....
buy buy buy
Posted by :
Guestby dec end cipla will be 340 for sure ..very strong fundamentals ...450 by next year this time ...
cipla - day trading
Posted by :
abhishek.anand
The stock looks to be consolidating around 303-305 levels. There is no reason, technically/fundamentally for it to go down. Any upmove on high volumes, and we may see 320-325 levels.
Shorting at around 310 may be hazardous. Keep a look at volumes....
cipla - day trading
Posted by :
vamshin
you`ve got to trust ur instincts..and hope some luck is by ur side...
It is at its all time high...so u have to take some risk..if u wanna make quick money
BTW i have a short position at 306.5
waiting for it go down:-)...
cipla - day trading
Posted by : boysiMy broker has advised me to short this stock at levels of Rs. 308, SL - 310, Target - Rs. 304. Should I follow his advise and short it. Please reply....
are we looking for a bonus
Posted by : Guestare we looking for a bonus ...its high time ...
buy cipla for long term
Posted by : ar_akmHi Kallme, Reasons for investment near 52 week high level?...
buy cipla for long term
Posted by : Kallmetop pick for investment right now....
CIPLA Offers H1N1 Drug to US
Posted by : wild bullI think this news didn`t help the stock move up... can any one tell why this stock is going down?...
CIPLA Offers H1N1 Drug to US
Posted by : TradeQ
Cipla unveils drug to combat H1N1 virus
Mumbai-based Cipla has launched Oseltamivir, a generic version of Roche s Tamiflu, used in the treatment of the H1N1 virus, under the brand name, Antiflu, in India. Cipla s Oseltamivir brand will cost Rs 475 for 10 capsules, and its 75 ml syrup will be similarly priced. Cipla s drug is also pre-qualified by the World Health Organisation (WHO). The H1N1 virus outbreak from the early part of the year was declared a pandemic in June and continues to spread globally. On Monday, the health ministry said more than 500 people have died from the flu in India since the first fatality was reported in August, with Maharashtra seeing the largest toll of 207 deaths. More than 14,000 people have tested positive for the flu across India during the period. More than 5,700 people have died worldwide since the virus was first discovered in April. Influenza, a perceivably benign condition, kills about 2.5 to 5 lakh people every year worldwide, according to the WHO. These are generally the elderly or those with chronic conditions of the lung, heart or kidney. The fatality pattern this year with the 2009 H1N1 virus has been unusual, with the virus attacking healthy adults and children and pregnant women, said JA Gogtay, medical director, Cipla. The company s shares closed at Rs 304.75 on the BSE (^BSESN : 16849.6 0) on Wednesday, up 1.43%. According to YK Hamied, chairman, Cipla, the company has offered to supply Antiflu to the United States. There is a shortage in the US. We have made an offer. It s up to them, he said. Cipla can produce two million doses of Oseltamivir a month if needed, he added....
